Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Global Market

0.85USD
14 Dec 2017
Change (% chg)

$-0.05 (-5.53%)
Prev Close
$0.90
Open
$0.90
Day's High
$0.93
Day's Low
$0.85
Volume
26,649
Avg. Vol
26,721
52-wk High
$4.95
52-wk Low
$0.72

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Mark Perrin

58 2015 Chairman of the Board, Chief Executive Officer

Christopher McNulty

40 2017 Principal Financial Officer and Principal Accounting Officer

Melanie Morel-Ferris

36 2017 Senior Director, Finance and Controller

Tamara Joseph

52 2014 Senior Vice President, Chief Compliance Officer, General Counsel

Pamela Stahl

48 2016 Chief Commercial Officer